Kindred Healthcare, Inc. (KND) Price Target Lowered to $7.50 at Royal Bank Of Canada
Kindred Healthcare, Inc. (NYSE:KND) had its target price trimmed by Royal Bank Of Canada from $9.00 to $7.50 in a research report released on Thursday. The firm currently has a sector perform rating on the health services provider’s stock.
Several other equities research analysts have also issued reports on KND. BidaskClub lowered shares of Kindred Healthcare from a sell rating to a strong sell rating in a research note on Tuesday, August 8th. Zacks Investment Research upgraded shares of Kindred Healthcare from a sell rating to a hold rating in a research note on Friday, August 11th. Mizuho reiterated a neutral rating and issued a $9.00 price target on shares of Kindred Healthcare in a research note on Monday, July 3rd. Finally, Deutsche Bank AG lowered their price target on shares of Kindred Healthcare from $13.00 to $10.00 and set a buy rating on the stock in a research note on Monday, August 7th. Five equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the stock. Kindred Healthcare presently has a consensus rating of Hold and an average price target of $9.17.
Shares of Kindred Healthcare (NYSE:KND) traded up 0.397% during midday trading on Thursday, reaching $6.325. 573,465 shares of the company were exchanged. The company’s market capitalization is $550.40 million. The stock has a 50-day moving average price of $7.62 and a 200 day moving average price of $9.24. Kindred Healthcare has a 52-week low of $5.65 and a 52-week high of $11.90.
Kindred Healthcare (NYSE:KND) last issued its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.03. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the business posted $0.38 earnings per share. The firm’s quarterly revenue was down 4.6% on a year-over-year basis. Equities research analysts expect that Kindred Healthcare will post $0.35 EPS for the current fiscal year.
Institutional investors and hedge funds have recently made changes to their positions in the company. TFS Capital LLC bought a new position in shares of Kindred Healthcare in the 1st quarter valued at about $104,000. Point72 Asia Hong Kong Ltd bought a new position in shares of Kindred Healthcare in the 1st quarter valued at about $121,000. Janus Henderson Group PLC bought a new position in shares of Kindred Healthcare in the 2nd quarter valued at about $130,000. Two Sigma Securities LLC grew its position in shares of Kindred Healthcare by 54.5% in the 1st quarter. Two Sigma Securities LLC now owns 15,632 shares of the health services provider’s stock valued at $131,000 after acquiring an additional 5,511 shares during the period. Finally, Paloma Partners Management Co bought a new position in shares of Kindred Healthcare in the 1st quarter valued at about $133,000. 88.14% of the stock is owned by institutional investors.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.